Skip to main content

IonQ Inc

For the period ended Dec 31, 2023. Filed Feb 28, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 28, 2024

IONQ$34.99-1.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

(in thousands)

Year EndedDecember 31,
20232022
Cash flows from operating activities:
Net loss$(157,771)$(48,511)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization10,3755,604
Non-cash research and development arrangements520520
Stock-based compensation69,74331,456
(Gain) loss on change in fair value of warrant liabilities19,206(30,136)
Amortization of premiums and accretion of discounts on available-for-sale securities(9,746)(1,577)
Other, net1,474441
Changes in operating assets and liabilities:
Accounts receivable(8,175)(1,510)
Prepaid expenses and other current assets(14,413)(7,012)
Accounts payable2,1881,060
Accrued expenses3,3191,344
Unearned revenue2,6043,892
Other assets and liabilities1,865(269)
Net cash provided by (used in) operating activities$(78,811)$(44,698)
Cash flows from investing activities:
Purchases of property and equipment(13,703)(9,336)
Capitalized software development costs(4,558)(2,179)
Intangible asset acquisition costs(1,288)(1,049)
Purchases of available-for-sale securities(298,445)(605,689)
Maturities and sales of available-for-sale securities386,760310,045
Business acquired—(848)
Net cash provided by (used in) investing activities$68,766$(309,056)
Cash flows from financing activities:
Proceeds from stock options exercised1,9541,059
Other financing, net(193)37
Net cash provided by (used in) financing activities$1,761$1,096
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash(2)—
Net change in cash, cash equivalents and restricted cash(8,286)(352,658)
Cash, cash equivalents and restricted cash at the beginning of the period46,367399,025
Cash, cash equivalents and restricted cash at the end of the period$38,081$46,367
Supplemental disclosures of non-cash investing and financing transactions
Property and equipment purchases in accounts payable and accrued expenses$773$485
Intangible asset purchases in accounts payable and accrued expenses254164
Operating lease right-of-use assets subject to lease liability2,380—
Remeasurement of operating lease right-of-use assets due to lease modification(849)—
Noncash reclassification of warrant liabilities to equity upon exercise208
Bonus settled in restricted stock units3,923473
Net share settled stock option exercises291—

a

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.